(Q36128917)

12 August 2017

title

Oral vaccination of dogs with recombinant rabies virus vaccines (English)

1 reference

12 August 2017

0 references

1 reference

rabies virus

1 reference

based on heuristic

inferred from title

author

Charles Edward Rupprecht

1

object named as

Charles E Rupprecht

1 reference

12 August 2017

10

Bernhard Dietzschold

1 reference

12 August 2017

2

Cathleen A Hanlon

1 reference

12 August 2017

3

Jesse Blanton

1 reference

12 August 2017

8

Lillian A Orciari

1 reference

12 August 2017

Jamie Manangan

4

1 reference

12 August 2017

Patricia Morrill

5

1 reference

12 August 2017

Staci Murphy

6

1 reference

12 August 2017

Michael Niezgoda

7

1 reference

12 August 2017

Carolin L Schumacher

9

1 reference

12 August 2017

publication date

8 April 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

111

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

101-105

1 reference

Pathogenicity of SAD rabies vaccine given orally in chacma baboons (Papio ursinus)

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

New approaches to the development of live attenuated rabies vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

New approaches to the prevention and eradication of rabies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Field trial with oral vaccination of dogs against rabies in the Philippines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Assay of oral vaccination of dogs against rabies in Tunisia with the vaccinal strain SADBern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Elimination of rabies from red foxes in eastern Ontario

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Rationale and prospects for rabies elimination in developing countries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Genetic engineering of live rabies vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Molecular epidemiology of rabies epizootics in Texas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Human infection due to recombinant vaccinia-rabies glycoprotein virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Infectious rabies viruses from cloned cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Progress and setbacks in the oral immunisation of foxes against rabies in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

An update on safety studies of SAD B19 rabies virus vaccine in target and non-target species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Immunogenicity of an E1-deleted recombinant human adenovirus against rabies by different routes of administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Oral rabies vaccine: evaluation of its infectivity in three species of rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Oral Vaccination of Mice with Adenoviral Vectors Is Not Impaired by Preexisting Immunity to the Vaccine Carrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

Oral wildlife rabies vaccination field trials in Europe, with recent emphasis on France

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2005.03.017

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2005.03.017

1 reference

12 August 2017

1 reference